![Joy Phumaphi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joy Phumaphi
Direktor/Vorstandsmitglied bei MMV Medicines for Malaria Venture
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Douglas Harper | M | - |
Development Media International Associates CIC
![]() Development Media International Associates CIC Miscellaneous Commercial ServicesCommercial Services Development Media International Associates CIC engages in evidence-based media campaigns to change behaviors and improve lives in low-income countries. The non-profit company is based in London, UK. The British company was founded in 2005. The CEO is Roy Head. | - |
Mark Adams | M | 60 |
Development Media International Associates CIC
![]() Development Media International Associates CIC Miscellaneous Commercial ServicesCommercial Services Development Media International Associates CIC engages in evidence-based media campaigns to change behaviors and improve lives in low-income countries. The non-profit company is based in London, UK. The British company was founded in 2005. The CEO is Roy Head. | - |
Roy Head | M | - |
Development Media International Associates CIC
![]() Development Media International Associates CIC Miscellaneous Commercial ServicesCommercial Services Development Media International Associates CIC engages in evidence-based media campaigns to change behaviors and improve lives in low-income countries. The non-profit company is based in London, UK. The British company was founded in 2005. The CEO is Roy Head. | - |
David Reddy | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | 14 Jahre |
Per Wold-Olsen | M | 76 |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Michael Ferguson | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Robert C. Hornik | M | - |
Development Media International Associates CIC
![]() Development Media International Associates CIC Miscellaneous Commercial ServicesCommercial Services Development Media International Associates CIC engages in evidence-based media campaigns to change behaviors and improve lives in low-income countries. The non-profit company is based in London, UK. The British company was founded in 2005. The CEO is Roy Head. | - |
Wendy R. Sanhai | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Robert Newman | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Yuli Ismartono | F | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Winston E. Gutteridge | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | 15 Jahre |
David Brandling-Bennett | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Gabriel Jaramillo-Sanint | M | 74 |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Alan Court | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
David L. Heymann | M | - |
Development Media International Associates CIC
![]() Development Media International Associates CIC Miscellaneous Commercial ServicesCommercial Services Development Media International Associates CIC engages in evidence-based media campaigns to change behaviors and improve lives in low-income countries. The non-profit company is based in London, UK. The British company was founded in 2005. The CEO is Roy Head. | - |
Elizabeth J. Linder | F | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Dennis Schmatz | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Paul Kaba Thieba | M | - |
Development Media International Associates CIC
![]() Development Media International Associates CIC Miscellaneous Commercial ServicesCommercial Services Development Media International Associates CIC engages in evidence-based media campaigns to change behaviors and improve lives in low-income countries. The non-profit company is based in London, UK. The British company was founded in 2005. The CEO is Roy Head. | - |
Konji Sebati | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Dominique Limet | M | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Andrea Buscaglia | M | 60 |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Andrea Lucard | F | - |
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweiz | 16 | 72,73% |
Vereinigtes Königreich | 6 | 27,27% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Joy Phumaphi
- Persönliches Netzwerk